Merck's lung cancer drug poses unacceptable safety risks to patients

Overview Debates Related claims Topics Sources

Geraldine Levano reached more than three years of cancer remission following her stage 3 colorectal cancer treatments.

Radon is the second leading cause of lung cancer after smoking, causing an estimated 21,000 deaths annually

Mass General Brigham Cancer Institute will offer services across eight cancer specialties, including gastrointestinal and thoracic oncology, by November 2026, MGB said

In the Sungkyunkwan University cohort, each 1-unit increase in biological age acceleration based on nine routine blood markers was associated with a 7% higher risk of early-onset colorectal adenocarcinoma.

The original version of Freenome's blood-based SimpleScreen CRC screening test is already FDA-approved for colorectal cancer surveillance.

A study found advanced stage at diagnosis accounted for 24.9% of excess rural breast cancer deaths, while radiation omission and chemotherapy omission accounted for 11.4% and 7.9% respectively.

The American College of Obstetricians and Gynecologists guidelines recommend systemic hormone replacement therapy with estrogen and progestogen for women with a uterus to mitigate endometrial cancer risk from estrogen-stimulated uterine lining growth, or estrogen alone without

The metabolic health benefits of GLP-1 drugs outweigh their dermatological side effects

The transaction includes BioReference Health's proprietary 4Kscore test, an FDA-approved blood test used to evaluate the likelihood of aggressive prostate cancer prior to a biopsy.

Glioblastoma is a significant topic in the health domain with ongoing developments and regulatory implications.

FDA approves Elevar Therapeutics' Lyrfigtu for bile duct cancer with FGFR2 alterations

Moderna's personalized mRNA melanoma vaccine cuts cancer recurrence risk by half in five-year trial results

The FDA drug recall system catches contamination issues before they reach patients

Pharmaceutical manufacturing quality standards are sufficient to prevent particulate contamination

The FDA also announced multiple food recalls in October 2026 including Listeria-contaminated smoked salmon and Salmonella-contaminated broccoli seeds.

The recall was conducted with the knowledge of the U.S. Food and Drug Administration.

Argatroban is a direct thrombin inhibitor indicated for prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia and as an anticoagulant in percutaneous coronary intervention.

To date, Par Health has not received any reports of adverse events related to this recall.

Administration of Argatroban Injection containing particulate matter could cause life-threatening adverse health consequences including pulmonary emboli, blood vessel occlusions, and vein inflammation leading to clotting.

Par Health USA recalled 22 lots of Argatroban Injection 250 mg/2.5 mL (100 mg/mL) due to the presence of particulate matter including cellulose, polystyrene, polyethylene terephthalate, stopper material, and possibly stainless steel.